secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001640334-25-000719
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Oct 20, 2025
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 23, 2025 for non-compliance with $1.00 minimum bid price requirement.
- Must regain compliance by Oct 20, 2025; closing bid price must meet or exceed $1.00 for 10 consecutive business days.
- Possible second 180-day extension if other listing standards met; company may implement a reverse stock split.
- No immediate effect on listing; company intends to monitor bid price and evaluate available options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425000719/0001640334-25-000719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425000719/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-000719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer